Phosphoglycerate mutases catalyze the inter-conversion of 2-and 3-phosphoglycerate in the glycolytic and gluconeogenic pathways. They exist in two unrelated forms that are either cofactor (2,3-diphosphoglycerate) -dependent or independent. The two enzymes have no similarity in amino acid sequence, tertiary structure or catalytic mechanism. Certain organisms including vertebrates have only the cofactor-dependent form whereas other organisms can possess the independent form or both. Caenorhabditis elegans has been predicted to have only independent phosphoglycerate mutase. In this study we have cloned and produced recombinant independent phosphoglycerate mutases from C. elegans and the human parasitic nematode Brugia malayi. They are 70% identical to each other and related to known bacterial, fungal and protozoan enzymes. The nematode enzymes possess the catalytic serine and other key amino acids proposed for catalysis and recombinant enzymes showed typical phosphoglycerate mutase activities in both the glycolytic and gluconeogenic directions. The gene is essential in C. elegans as reduction of its activity by RNA interference led to embryonic lethality, larval lethality and abnormal body morphology. Promoter reporter analysis indicated widespread expression in larval and adult C. elegans with highest levels apparent in the nerve ring, intestine and body wall muscles. The enzyme was found in a diverse group of nematodes representing the major clades indicating it is conserved throughout this phylum. Our results demonstrate that nematodes, unlike vertebrates, utilize independent phosphoglycerate mutase in glycolytic and gluconeogenic pathways, and it is likely essential for all nematodes.
INTRODUCTION
The genome of the free-living nematode Caenorhabditis elegans has been used widely as a model to understand molecular pathways common to nematodes and mammals on the basis of conserved evolution. However, nematodes as a group also have features that distinguish them from mammals. It is likely that some of these characteristics are the result of developmental and/or physiological processes potentially involving nematode specific genes. Indeed, genome analysis has shown that C. elegans possesses many genes which do not have orthologs in mammals (1, 2) . While a few of these unique genes are known to participate in essential processes such as cuticle biosynthesis and sex determination (3), most of them remain uncharacterized.
With a view to gaining an improved understanding of nematode biology, we are focusing on genes absent in mammals that showed a defect when disrupted in high throughput RNA interference (RNAi) studies performed in C. elegans (4) (5) (6) (7) . One of the genes identified was cofactor-independent phosphoglycerate mutase (iPGM) (EC 5.4.2.1). PGM's catalyze the interconversion of 2-and 3-phosphoglycerate in the glycolytic and gluconeogenic pathways.
Although these pathways are highly conserved among different organisms, two distinct PGM enzymes are known to exist: iPGM and the co-factor-dependent phosphoglycerate mutase, dPGM. The sizes, amino acids (aa) sequence composition, three dimensional structure and catalytic mechanisms of these two enzymes are vastly dissimilar. iPGM is comprised of approximately 500 aa and catalyzes the intramolecular transfer of the phospho group on monophosphoglycerates through a phosphoserine intermediate (8, 9) . In contrast, dPGM is composed of approximately 250 amino acids, and catalyzes the intermolecular transfer of the phospho group between the monophosphoglycerates and the cofactor (2,3-diphosphoglycerate) through a phosphohistidine intermediate (10) . Vertebrates are known to possess the dPGM form exclusively, whereas in other organisms the distribution of the two forms has been considered complex and unpredictable, since either dPGM or iPGM or both forms may be present (11, 12) .
While the two forms of PGM are distinct, the amino acid sequence of each form, when present, is conserved from bacteria to higher eukaryotes (13).
Parasitic nematodes of plants, animals and humans are found worldwide and cause serious economic and health problems. Filarial nematodes, such as Brugia malayi, lead to particularly debilitating infections in humans and other mammals. Current treatments for nematode infections are inadequate. The identification of essential nematode genes that are absent from mammals may lead to the discovery of new drug targets and therapies.
In this study we performed a detailed characterization of the function of C. elegans iPGM in vivo, and report that iPGM is present in many parasitic nematode species. We provide molecular and biochemical studies on the iPGM enzymes from C. elegans and B. malayi, representing the first analysis of iPGM from metazoans.
Identification of iPGM as a non-mammalian gene with an RNAi phenotype in C. elegans -C. elegans iPGM (Ce-iPGM) was identified using a bioinformatic method relying on gene function data from large scale RNAi screens. Predicted proteins in Wormbase (www.wormbase.org, release version WS110, October, 2003) with a non-wild type entry in the RNAi phenotype field were retrieved and used to query the mouse and human genomes using BLASTP (14) . Ce-iPGM (corresponding to predicted gene F57B10.3) was identified as a member of a group of genes that do not have orthologs in these mammalian genomes (E-value cut-off score = 10 -10 ).
Identification of iPGM enzymes in parasitic nematodes and other eukaryotes -Ce-iPGM was used to query NCBI databases for corresponding orthologs in C. briggsae, parasitic nematodes and other eukaryotes. A number of genomic and cDNA sequences and EST's were identified using the TBLASTN program (14) (E-value cut-off score = 10 -10 ). Full-length iPGM sequences were retrieved for further analyses including multiple sequence alignment and construction of phylogenetic trees using the ClustalW program (15) .
RNAi in C. elegans -C. elegans culture and handling were performed following standard procedures (16). A 995bp fragment of Ce-iPGM was amplified from a mixed-stage C. elegans cDNA pool, or a cloned and sequenced full-length cDNA, using primers containing the T7 promoter sequence. The primer sequences were: forward (5'-aatacgactcactataggACCAGTTATGGACAAGCTGTG-3') and reverse (5'-aatacgactcactataggTTGGACTGGGCACTAAACACC-3'), with the T7 promoter sequence shown in lower case. The PCR products were purified, and used for in vitro transcription with T7 RNA polymerase using the HiScribe TM RNAi Transcription Kit (New England Biolabs).
The synthesized dsRNA was purified using an RNeasy column (Qiagen), and eluted into H 2 O.
The purified dsRNA was injected into the germ line of C. elegans young adult hermaphrodites (wild type N2) (17). Injected worms were allowed to recover on NGM plates overnight before singling. Each injected worm was transferred to a fresh NGM plate every 8 or 16 hours over the course of 3 days. The F1 embryos laid on each plate were counted immediately after transferring the injected worm. The L1 larvae that emerged from eggs on each plate were counted after 24 hours. The plates were scored again 2 days later to assess worm growth and morphological defects. Embryos that failed to hatch were scored as embryonic lethal and L1 larvae that failed to grow were scored as larval lethal. dsRNA's corresponding to fragments of the unc- 22 (17) and pos-1 (18) genes were synthesized similarly and used as controls. carrying the reporter on extra-chromosomal arrays (IP159: nbEx50) were identified following coinjection of the reporter (~17 µg/ml) with the pRF4 plasmid (~57 ug/ml) that carries a dominant
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Rol-6(su1006) gene as the transgenic marker (19).
Cloning and over-expression of iPGM enzymes from C. elegans and B. malayi -Full- Ce-iPGM, cultures were grown at 30ºC and induced with 0.1 mM isopropylthio-β-Dgalactoside (IPTG, Sigma) at 15ºC overnight. Bm-iPGM was produced by growing cultures at 37ºC and inducing with 0.1 mM IPTG for 3 hours at 37ºC. The His-tagged proteins were extracted, and purified on nickel columns (Qiagen) using native conditions according to the manufacturer's instructions. An elution buffer (40 mM NaH 2 PO 4 , 300 mM NaCl, pH 8.0) containing 60 mM imidazole was found to be optimal in releasing both His-tagged proteins from the nickel resin with a high level of purity.
PGM enzyme assay -iPGM activity was determined in forward and reverse directions using standard enzyme-coupled assays (12, 20) . In the forward reaction (glycolytic) the conversion of 3-phosphoglycerate (3-PG) to 2-phosphoglycerate (2-PG) is measured, whereas in the reverse direction (gluconeogenic) the conversion of 2-PG to 3-PG is assayed. In both cases, PGM activity was determined indirectly by measuring the consumption of NADH, which is monitored at 340nm. The amount of NADH being oxidized to NAD corresponds to the amount of enzyme product (2-PG in the forward direction or 3-PG in the reverse direction) produced in the PGM reaction. Reactions were performed at 30ºC for 5 minutes with data collected at 10-second intervals using a Beckman DU 640 spectrophotometer. In the forward reaction, iPGM was added to 1 ml assay buffer (30 mM Tris-HCl pH 7.0, 5 mM MgSO 4 , 20 mM KCl, 0.15 mM NADH) containing 1 mM ADP, 10 mM 3-PGA (Sigma P8877), 2.5 units each of enolase (Sigma E6126, EC 4.2.1.11), pyruvate kinase (Sigma P7768, EC 2.7.1.40) and lactate dehydrogenase (Sigma L2518; EC 1.1.1.27). In the reverse reaction, iPGM was added to 1ml assay buffer containing 1 mM ATP, 10 mM 2-PG (Sigma P0257), 2.5 units each of phosphoglycerate kinase (Sigma P7634; EC 2.7.2.3) and glyceraldehyde 3-phosphate dehydrogenase (Sigma G0763; EC 1.2.1.12). One unit of PGM activity is defined as the amount of activity that is required for the conversion of 1.0 µM NADH to NAD per minute in the above assay conditions.
RESULTS
Identification and cloning of iPGM from C. elegans and B. malayi -Ce-iPGM was identified in this study as a member of a set of C. elegans genes that has no apparent similarity to any mammalian genes and showed a visible phenotype in high throughput RNAi studies (4-7). CeiPGM is encoded by a single predicted gene F57B10.3, which potentially can produce two splice forms, F57B10.3a and F57B10.3b, based on existing C. elegans EST's (Wormbase). They encode ORFs of 539 and 521 aa, respectively, differing only in 18 aa at the N-terminus. cDNA corresponding to predicted ORF of F57B10.3a was amplified by PCR and sequenced and found to match the predicted intron-exon junctions. Ce-iPGM was used to query the nematode EST databases and partial cDNA sequences encoding B. malayi iPGM (Bm-iPGM) were identified.
A full-length Bm-iPGM cDNA was amplified and cloned from a cDNA pool and subsequently sequenced. The Bm-iPGM was predicted to encode a 515 aa protein.
Both C. elegans and B. malayi deduced proteins are typical in size of iPGM's and appear to be canonical iPGM enzymes based on aa sequence comparisons. Sequence alignment (Fig. 1) shows that they possess the catalytic serine and 13 other residues predicted to be involved in catalysis based on structural studies of the biochemically characterized Bacillus stearothermophilus iPGM (8, 9, 21) . The nematode enzymes share approximately 40-42% amino acid identity and 59-62% similarity to B. stearothermophilus iPGM (22) and have 70% amino acid identity and approximately 82% similarity to each other (Fig. 1) . They are less related to the experimentally verified iPGM enzymes from the kinetoplastid protozoans Trypanosoma brucei and Leishmania mexicana (26-28% identical and 47-50% similar) (23, 24) , although the similarity extends over the full length of the proteins.
Ce-iPGM plays an essential role in development -To determine the role of Ce-iPGM in vivo,
its endogenous activity was reduced by RNAi (17) and the effects on C. elegans development were monitored at various time intervals following injection. Several defects were observed, most notably embryonic lethality (Fig. 2) . The degree of embryonic lethality at different time periods after dsRNA injection was carefully monitored. Embryos laid 18-26 hrs after injection of Ce-iPGM dsRNA hatched normally and continued to develop normally (data not shown).
Embryos laid 26-42 hrs after injection showed only a low level of embryonic lethality (~22%).
Strikingly, embryonic lethality increased significantly after 42 hrs, with most embryos laid 42-66 hrs post injection failing to hatch (94-97% embryonic lethality) ( Fig. 2A) . In contrast, RNAi inactivation of control unc-22 (17) and pos-1 (18) genes resulted in full penetrant phenotypes in progeny produced by 18 hrs post injection (Fig. 2B) . The phenotype severity and time course of the effects observed with iPGM RNAi were comparable following administration of dsRNA at 1 mg/ml ( Fig. 2A) , and at higher (3 mg/ml) or lower (0.4 mg/ml) concentrations (data not shown).
When the embryos that failed to hatch were examined further, it was observed that development was arrested at different time points during embryogenesis (Fig. 2C-D) . In some of the larvae that escaped embryonic lethality, additional defects were noted including sluggish movement (data not shown), variable abnormal body morphology, developmental arrest and lethality ( Fig. 2F-J) . In a total of 31 larvae that developed from embryos collected at 42-50 hrs post injection, larval lethality was 19%. The larval lethality rate increased to 37% in the 19 surviving larvae that resulted from embryos collected at 50-65 hrs post injection.
To further address the in vivo function of Ce-iPGM, its spatial and developmental expression was examined in transgenic C. elegans carrying an iPGM::GFP transcription reporter construct. GFP expression was observed in most cells, with higher levels in the nerve ring, intestine and muscles of the body wall (Fig. 3) . The distribution pattern and expression levels were consistent in larval stages and adult worms.
Recombinant Ce-iPGM and Bm-iPGM have PGM activity -In order to verify their PGM activities, Ce-iPGM and Bm-iPGM were over-expressed in E. coli as C-terminal 6-Histagged proteins for enzymatic analysis. The ORF corresponding to the C. elegans shorter splice variant was selected for expression as the 18 aa extension present in the longer form does not match any known iPGM sequence. Ce-iPGM and Bm-iPGM recombinant proteins (approximately 60 kDa in size) were abundantly expressed and subsequently purified (Fig. 4A) .
PGM activity was measured using standard enzyme-coupled assays (12, 20) . Both Ce-iPGM and Bm-iPGM showed PGM activity in the glycolytic (conversion of 3-PG to 2-PG) (Fig. 4B) and gluconeogenic directions (2-PG to 3-PG) (Fig. 4C) , as evidenced by the consumption of NADH by the coupling enzymes. The slope resulting from the change in NADH concentration was used to calculate specific activities. The specific activities in the forward reaction for CeiPGM and Bm-iPGM were approximately 40 and 93 units/mg, respectively. For the reverse reaction, the activities for Ce-iPGM and Bm-iPGM were 72 and 256 units/mg, respectively.
The addition of 2,3-diphosphoglycerate, the cofactor for dPGM (11) , did not alter these activities. Likewise the enzyme activities were not affected by the addition of vanadate, a known inhibitor of dPGM (25) (data not shown).
Distribution and conservation of iPGM and dPGM enzymes in nematodes and other eukaryotes -
To investigate if iPGM is present in other nematodes, Ce-iPGM was used as a query to search the recently sequenced genome of the closely-related, free-living nematode C. briggsae (26) , and the ~300,000 EST sequences available from 30 different parasitic nematode species (27) .
The C. briggsae genome was found to contain a predicted gene (CBG12654) that encodes a protein with 95% amino acid identity to Ce-iPGM. In addition, 38 nematode EST's obtained from a highly diverse group of parasitic nematodes were found to match Ce-iPGM. These included 16 non-overlapping EST's from a total of 12 parasitic species found in humans (B.
malayi, Trichinella spiralis, Onchocerca volvulus, Strongyloides stercoralis, Necator americanus), animals (Trichuris muris, Litomosoides sigmodontis, Haemonchus contortus, Ostertagia ostertagi), and plants (Globodera rostochiensis, Meloidogyne incognita, Heterodera glycines).
When these matching sequences were sorted among the 5 major clades of the phylum Nematoda (3), they were found in all 4 clades that have existing EST sequences (Fig. 5A) . In contrast, no dPGM sequences were found in the C. elegans and C. briggsae genomes, nor the nematode EST database when human dPGM (GenBank" gi130353) (28) was used as the query. The same human dPGM query identified a large number of orthologs in other organisms ranging from bacteria to mammals (data not shown).
The relationship of the nematode iPGM's to other eukaryotic IPGM's was examined using multiple sequence alignments. Ce-iPGM was used to query available databases and orthologs were identified in fungi, protozoa and plants. A phylogenetic tree was constructed using full-length iPGM sequences from diverse species that represent the major taxa (Fig. 5B), with a distantly related iPGM from an archaeon, Pyrococcus furiosus (29) included as an outgroup in displaying the tree. The iPGM enzymes from C. elegans and B. malayi clustered together as expected from the high degree of conservation between them (70% aa identity). The C. elegans enzyme was more closely related to putative fungal iPGM enzymes (41-53% identity) than those found in protozoa (26-30% identity) and plants (~32% identity). It was 42% identical to the B. stearothermophilus enzyme, chosen to represent bacteria.
DISCUSSION
iPGM has been found mainly in bacteria and plants, and predicted to exist in C. elegans (12, 30) . In this study we provide biochemical characterization of C. elegans iPGM and confirmation of its essential role in development. We also cloned and characterized iPGM from the parasitic nematode B. malayi. We discovered that iPGM is likely present in all nematodes as indicated by the presence of numerous matching ESTs from a diverse collection of parasitic species. In sharp contrast, dPGM, the form of the enzyme found in vertebrates, was not detected amongst any of the available nematode sequence databases.
We demonstrate that recombinant iPGM enzymes from C. elegans and B. malayi are active in both glycolytic and gluconeogenic directions. The specific activities were similar to those reported for the recombinant iPGM from T. brucei (23) , but they were approximately 10-fold lower than the enzyme from the thermophilic bacterium B. stearothermophilus (22) . Like other iPGM's, the activity of the nematode enzymes was not affected by the addition of 2,3-diphosphoglycerate, the cofactor for dPGM or vanadate, a known inhibitor of dPGM. The nematode enzymes were clearly active in neutral buffer containing magnesium ions like the enzymes from E. coli (12) and T. brucei (31) . However it would be of interest in the future to evaluate the effect of other ions on activity since cobalt is preferred by the iPGM from T. brucei (31) and L. mexicana (24) , while manganese is optimal for iPGM from Bacillus species (22, 32) and present in E. coli iPGM (12) .
As expected from its involvement in a fundamental metabolic pathway, we found CeiPGM expressed throughout the worm in all developmental stages. The enzyme was most abundant in cells that would be expected to have a higher metabolic rate, such as the frequently contracting body wall muscles, nerve ring and intestinal cells. Disruption of Ce-iPGM by RNAi resulted in variable defects including embryonic and larval lethality. These defects were initially detected in high throughput RNAi screens (4) and characterized in more detail in this study. An interesting finding from our detailed analysis was the apparent delay in the onset of the RNAi effect compared to other genes, and an increasing potency over time. For other genes, the progeny produced from the microinjected mother start to show potent and consistent phenotypes about 6 hours after injecting dsRNA (17). For iPGM, a low level effect was detected only by 26 hours and then reached maximum potency at 42-66 hrs post injection. This delay and incomplete penetrance may be the result of a slower depletion of iPGM transcripts, or a stable, abundant reservoir of the protein, or both. Alternatively, it may reflect the involvement of a non-sustainable salvage regulation in response to the depletion of iPGM. The delayed RNAi effect peculiar to this gene may have partly contributed to the different phenotypes observed for iPGM in the various large-scale RNAi screens (4, (33) (34) (35) . Nevertheless, it is likely that 100% embryonic lethality would be observed when iPGM activity is completely deleted in a strain carrying a genetic null mutation of iPGM.
Our studies clearly demonstrate an essential role for iPGM in C. elegans. Similarly, essential roles for iPGM have also been reported in two bacterial species. Deletion of the iPGM gene in a spore forming bacterium, Bacillus subtilis, resulted in extremely slow growth and an inability to produce spores (36). Inactivation of the iPGM locus by a transposon insertion in the tomato bacterial pathogen Pseudomonas syringae resulted in a mutant strain that could not grow or infect tomatoes (37) . The demonstration of essential roles of iPGM in these organisms suggests it is possible to target this enzyme in certain pathogens. Our discovery that nematodes have only iPGM in their genomes indicates that it represents an excellent drug target against parasitic nematodes sinceit is absent from their human and other vertebrate hosts.
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